DFS analysis (Figure 2B) shows high SMARCA4 expression is correlated with poor prognosis for the TCGA cases of ACC (p = 0.0023), BRCA (p = 0.034), and uterine carcinosarcoma (UCS, p = 0.017). This evidence concerns the gene SMARCA4 and adrenal cortex carcinoma.